Product Description

Caspogin 50 mg Injection is a prescription antifungal medicine containing Caspofungin 50 mg. It is marketed by Cipla Ltd.
Caspofungin belongs to the echinocandin class of antifungal medicines.
It is supplied as a lyophilized powder for intravenous infusion in a single-dose vial.

🔹 Key Uses
Treatment of invasive candidiasis and candidemia
Treatment of esophageal candidiasis
Management of certain intra-abdominal Candida infections
Used for invasive aspergillosis in patients who are refractory to or intolerant of other therapies
May also be used as empirical antifungal therapy in selected high-risk patients with persistent fever.

🔹 Composition
Active ingredient: Caspofungin
Strength: 50 mg/vial
Form: Powder for solution for intravenous infusion
Caspofungin is provided as caspofungin acetate equivalent to 50 mg caspofungin.

🔹 How It Works
Caspofungin inhibits β-(1,3)-D-glucan synthesis, an important component of the fungal cell wall.
This weakens the fungal cell wall and interferes with fungal growth and survival.

🔹 Key Benefits
Provides systemic antifungal therapy for serious fungal infections
Effective against clinically important Candida infections
Used in selected cases of invasive Aspergillus infection
Suitable for hospital-based antifungal treatment when IV therapy is required

🔹 Administration
Administered only by a healthcare professional through intravenous infusion.
The dosage and duration depend on the type and severity of infection, patient age, liver function and clinical response.
The powder must be properly reconstituted and diluted before administration; it should not be self-administered.

🔹 Possible Side Effects
Fever
Headache
Nausea
Diarrhea
Injection/infusion-site reactions
Changes in liver enzymes
Rash or other hypersensitivity reactions

🔹 Precautions
Use under specialist medical supervision.
Inform the healthcare provider about liver disease, allergies and other medicines being taken.
Liver function may require monitoring during treatment.
Caspofungin should not be mixed or co-infused with incompatible medicines or solutions; product-specific preparation instructions must be followed